Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
SLNO Transcript
Soleno Therapeutics, Inc. (SLNO) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call summary and Q&A indicate a positive outlook with strong financial health, reduced expenses, and strategic expansion plans in the U.S. and EU. Despite some uncertainties and management's reluctance to provide specific metrics, the company's proactive market strategies and significant capital raise suggest optimism. The market cap suggests moderate volatility, aligning with a positive sentiment rating of 2% to 8%.
Soleno Therapeutics, Inc. (SLNO) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Neutral9-5
Soleno Therapeutics, Inc. (SLNO) Presents At Cantor Global Healthcare Conference 2025 Transcript
Neutral9-4
Soleno Therapeutics, Inc. (SLNO) Q2 2025 Earnings Call Transcript
Positive8-7
The earnings call highlights a successful launch of VYKAT XR with strong initial patient engagement and reduced net loss due to revenue generation. The Q&A section reveals confidence in market position and no new safety issues, despite some reluctance to provide specific data. The company's strong cash position and plans for European expansion further support a positive outlook. Given the market cap of approximately $1.54 billion, the stock price is likely to experience a moderate positive movement of 2% to 8% over the next two weeks.
SLNO Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
